Literature DB >> 1834090

Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims.

S Matsubara1, R C Arora, H Y Meltzer.   

Abstract

The density of 5-HT1A binding using 3H-8-hydroxy-2-(di-n-propyl-amino) tetralin (8-OH-DPAT) as binding ligand, was studied in human frontal cortex of suicide victims and normal controls who died due to medical disease or accidentally. There was no difference in the maximum number of binding site (Bmax) or Kd (an inverse measure of affinity) of 5-HT1A receptor binding sites between normal controls and the entire group of suicide victims. However, nonviolent suicides had significantly higher Bmax (22-25%) compared to both controls and violent suicides. A negative correlation between age and Bmax of 5-HT1A binding sites was found in male controls but not in female controls or suicide victims. This relationship was less apparent among the male controls over age 60.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834090     DOI: 10.1007/bf01244944

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  46 in total

1.  Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects.

Authors:  R C Arora; H Y Meltzer
Journal:  Am J Psychiatry       Date:  1989-06       Impact factor: 18.112

2.  Brain 5-HT-2 receptors and suicide.

Authors:  F Owen; A J Cross; T J Crow; J F Deakin; I N Ferrier; R Lofthouse; M Poulter
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

3.  Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

Authors:  T J Crow; A J Cross; S J Cooper; J F Deakin; I N Ferrier; J A Johnson; M H Joseph; F Owen; M Poulter; R Lofthouse
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

Review 4.  5-Hydroxytryptamine receptor subtypes.

Authors:  S J Peroutka
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

5.  Aggression in humans correlates with cerebrospinal fluid amine metabolites.

Authors:  G L Brown; F K Goodwin; J C Ballenger; P F Goyer; L F Major
Journal:  Psychiatry Res       Date:  1979-10       Impact factor: 3.222

6.  Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2-adrenoceptor mediated function in mice.

Authors:  G M Goodwin; R J DeSouza; A J Wood; A R Green
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.

Authors:  M G Palfreyman; A K Mir; M Kubina; D N Middlemiss; M Richards; M D Tricklebank; J R Fozard
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

8.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.

Authors:  G A Kennett; C T Dourish; G Curzon
Journal:  Eur J Pharmacol       Date:  1987-02-24       Impact factor: 4.432

9.  5-HT receptor binding in post-mortem brain from patients with affective disorder.

Authors:  I G McKeith; E F Marshall; I N Ferrier; M M Armstrong; W N Kennedy; R H Perry; E K Perry; D Eccleston
Journal:  J Affect Disord       Date:  1987 Jul-Aug       Impact factor: 4.839

10.  Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.

Authors:  N W Pedigo; H I Yamamura; D L Nelson
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

View more
  29 in total

1.  Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents.

Authors:  Se-Won Lim; Juwon Ha; Dong-Won Shin; Hee-Yeon Woo; Kye-Hyun Kim
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

Review 2.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

Review 3.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

4.  Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.

Authors:  Craig A Stockmeier; Eimear Howley; Xiaochun Shi; Anna Sobanska; Gerard Clarke; Lee Friedman; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2009-02-12       Impact factor: 4.791

5.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

6.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

Review 7.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

8.  Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.

Authors:  Bernadeta Szewczyk; Paul R Albert; Ariel M Burns; Margaret Czesak; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lisa C Konick; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier; Mark C Austin
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-19       Impact factor: 5.176

9.  5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.

Authors:  Dustin W Wooten; Ansel T Hillmer; Jeffrey M Moirano; Dana L Tudorascu; Elizabeth O Ahlers; Maxim S Slesarev; Todd E Barnhart; Jogeshwar Mukherjee; Mary L Schneider; Bradley T Christian
Journal:  Neuroimage       Date:  2013-03-26       Impact factor: 6.556

Review 10.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.